Investment Thesis
Intuitive Surgical demonstrates exceptional financial health with 20.5% revenue growth, industry-leading 28.4% net margins, and fortress-like balance sheet (4.87x current ratio, zero debt). The company generates substantial free cash flow of $2.5B annually while maintaining pristine liquidity and returning capital through insider buying activity.
ISRG Strengths
- Exceptional revenue growth of 20.5% YoY with strong net income of $2.9B indicates robust surgical robot demand and market expansion
- Industry-leading profitability metrics: 66% gross margin, 29.3% operating margin, and 28.4% net margin demonstrate pricing power and operational efficiency
- Fortress balance sheet with $3.4B cash, zero debt, 17.8B equity, and 4.87x current ratio provides strategic flexibility and financial stability
- Free cash flow generation of $2.5B (24.7% FCF margin) with minimal capex requirements shows capital-efficient business model
- Strong insider confidence with 42 Form 4 filings in last 90 days suggesting management conviction
ISRG Risks
- Net income declined 0.7% YoY despite 20.5% revenue growth, indicating potential margin pressure or one-time charges requiring investigation
- High insider trading volume may reflect compensation vesting rather than bullish conviction
- Regulatory scrutiny in medical device sector and potential reimbursement pressures could impact future growth
- Dependence on surgical volumes and hospital capex spending during economic downturns
Key Metrics to Watch
- Net margin trend - monitor if margin decline continues or stabilizes
- Free cash flow conversion - ensure FCF remains above $2.4B annually
- Revenue growth sustainability - validate if 20%+ growth rate can be maintained
- Capital expenditure trajectory - watch for inflection in capex needs
- Operating leverage - track whether operating margin expands with scale
ISRG Financial Metrics
Revenue
$10.1B
Net Income
$2.9B
EPS (Diluted)
$7.87
Free Cash Flow
$2.5B
Total Assets
$20.5B
Cash Position
$3.4B
ISRG Profitability Ratios
Gross Margin
66.0%
Operating Margin
29.3%
Net Margin
28.4%
ROE
16.0%
ROA
14.0%
FCF Margin
24.7%
ISRG Balance Sheet & Liquidity
Current Ratio
4.87x
Quick Ratio
3.96x
Debt/Equity
0.00x
Debt/Assets
12.3%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: Mar 18, 2026 |
Data as of: 2025-12-31 |
Powered by Claude AI